Search
for
Sort by
Research 691–720 of 1000+
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- Scientific opinion on the tolerable upper intake level for selenium
- Expression and Function of Group IIE Phospholipase A2 in Mouse Skin
- Narrative review of facial gender surgery: approaches and techniques for the frontal sinus and upper third of the face
- Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence
- Lactate in skin homeostasis: metabolism, skin barrier, and immunomodulation
- Clinical Efficacy of Topical or Oral Soy Supplementation in Dermatology: A Systematic Review
- Behavioral Welfare Research for the Management of Sanctuary Chimpanzees (Pan troglodytes)
- Novel Combination Scalp Therapy for Androgenetic Alopecia: A Preliminary Retrospective Case Series with an Illustrative Four-Year Case
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science
- Comparison of the efficacy of platelet-rich plasma with topical minoxidil in treating patients with androgenetic alopecia: a systematic review of clinical trials
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- The integrated stress response fine-tunes stem cell fate decisions upon serine deprivation and tissue injury
- Can oral minoxidil be the game changer in androgenetic alopecia? A comprehensive review and meta-analysis comparing topical and oral minoxidil for treating androgenetic alopecia
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Are STK11 polymorphisms a predictor of the response to metformin in polycystic ovarian syndrome?
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Morphea: progress to date and the road ahead
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Prophylaxis and Management of Skin Toxicities
- Ptosis in childhood
- Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
- Oral Lichen Planus
- A new tool for conditional gene manipulation in a subset of keratin‐expressing epithelia
- Pathological Skin Scarring: From Mechanism to Targeted Local Therapy
- Enhancing Quercetin Bioavailability Attenuates Aging Phenotypes via the Gut Microbiota–Intestinal Barrier Axis in Aged Mice